Price movement over the last 24 hours
Bank Central Asia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Central Asia Tbk trades at Rp6,225 (market cap 753.61T, 180.06M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Central Asia Tbk is far larger — about 4577× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Central Asia Tbk is more actively traded (180.06M versus 214.9K). Which is the better fit depends on your goals.
| BBCA | OBAT | |
|---|---|---|
Market Cap | 753.61T | 164.65B |
Volume | 180.06M | 214.9K |
Lot | 1.8M | 2.15K |
Turnover | 1.11T | 51.97M |
Average Price | 6,176.89 | 241.85 |
Value | 1.11T | 51.97M |
Indicative Equilibrium Price | 6,225 | 240 |
Indicative Equilibrium Volume | 292.85K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Bank Central Asia, Tbk (the Company) was established under the name of N.V. Perseroan Dagang Dan Industrie Semarang Knitting Factory based on notarial deed No. 38 of Raden Mas Soeprapto dated 10 August 1955, which was then changed to PT Bank Central Asia based on notarial deed No. 144 of Ridwan Suselo dated 21 May 1974.
Read more on BBCA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →